Concept information
Terme préférentiel
Androstenediol
Type
-
mesh:Descriptor
Définition
- An intermediate in TESTOSTERONE biosynthesis, found in the TESTIS or the ADRENAL GLANDS. Androstenediol, derived from DEHYDROEPIANDROSTERONE by the reduction of the 17-keto group (17-HYDROXYSTEROID DEHYDROGENASES), is converted to TESTOSTERONE by the oxidation of the 3-beta hydroxyl group to a 3-keto group (3-HYDROXYSTEROID DEHYDROGENASES).
Concept générique
Synonyme(s)
- 521-17-5 (Androstenediol)
- 5-Androstene-3,17-diol
- 5-Androstene-3beta-17beta-Diol
- 95PS51EMXY
- Androst-5-ene-3,17-diol
- Androst-5-ene-3,17-diol, (3beta,17beta)-
- Androst-5-ene-3 beta,17 beta-Diol
- delta 5-Androstene-3 beta,17 beta-Diol
- Delta 5-Androstenediol
- Hermaphrodiol
Qualificatif(s) autorisé(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Action(s) pharmacologique(s)
Traductions
-
français
-
521-17-5 (Androstenediol)
-
95PS51EMXY
-
Androst-5-ene-3,17-diol, (3beta,17beta)-
-
Androst-5-ène-3bêta,17bêta-diol
URI
http://data.loterre.fr/ark:/67375/JVR-ZS87GXCV-Q
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}